Mortality News and Research

RSS

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.

9 Jan 2010

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Los Alamos National Laboratory (www.lanl.gov) has identified the Top 10 Laboratory science stories of 2009 based on global viewership of online media content and major programmatic milestones.

9 Jan 2010

Recent releases in Global Health

A Lancet Comment examines the "grossly insufficient" progress towards meeting the Millennium Development Goal (MDG) of reducing under-5 child mortality. "Accelerated progress can be achieved, even in the poorest environments, through: integrated, evidence-driven, and community-based programmes that focus on addressing the major causes of death, including pneumonia, diarrhoea, newborn disorders, malaria, HIV, and undernutrition; reaching the unreached with a basic package of interventions at large scale and achieving coverage with equity; and using data for action and advocacy," the comment concludes (You et al., 1/9).

9 Jan 2010

Health and development groups applaud Clinton speech; call for action

A broad coalition of organizations representing millions of Americans applauded today's statement by Secretary of State Hillary Clinton that the United States unequivocally supports the worldwide consensus that achieving universal access to reproductive health is critical for individual health, family well-being, broader economic development and a healthy planet.

9 Jan 2010

Ochsner Health System to acquire NSRMC

The private, not-for-profit Ochsner Health System today announced the signing of a definitive agreement to purchase NorthShore Regional Medical Center (NSRMC), the ambulatory surgery center and several pieces of property on which the facility is located in Slidell, Louisiana. The projected closing date is April 1, 2010: this purchase will expand Ochsner Health System to eight hospitals in Southeast Louisiana. The medical staff will remain "open," which is consistent with how the facility operates today.

9 Jan 2010

Also in global health news: Museveni on Uganda anti-gay bill; Zambia, India on collaboration; media examines water issues; Southern Sudan conflict

The Associated Press reports that Ugandan President Yoweri Museveni has said that the anti-gay bill to be considered late next month or early March by the country's parliament "is too harsh and [he] has encouraged his ruling National Resistance Movement Party to overturn the death sentence provision. Several lawmakers have agreed and say they will push to remove the statute."

9 Jan 2010

MUHC unveils new Lung Cancer Navigation Program

A diagnosis of lung cancer can come as a hard blow. The disease has one of the highest mortality rates of all cancers and the sheer complexity of therapy - often involving radiation, chemotherapy and surgery - can leave patients feeling confused and isolated. To help these patients navigate through the complicated treatment process and medical appointments, the MUHC has unveiled its new Lung Cancer Navigation Program (LCNP).

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

Following the results of the Angus Reid Strategies and the Applied Health Research Centre at Toronto's St. Michael's Hospital survey conducted on behalf of the Canadian Partnership Against Cancer finding that the majority of Canadians have a good understanding of the benefits of colorectal cancer screening, but are not taking action to get screened, the Colorectal Cancer Association of Canada ("CCAC") is doubling its efforts in 2010 to convince Canadians that they must be more proactive concerning their health and the onset of colorectal cancer.

7 Jan 2010

Data highlights importance of follow-up exams for patients with history of advanced adenomas

A new study examines the occurrence of interval colorectal cancer despite regular colonoscopy and highlights the importance of close follow-up for patients who have a history of advanced adenomas, which are precancerous polyps.

7 Jan 2010

Antiretroviral therapy improves health outcomes for HIV patients

High antiretroviral therapy adherence, which has been shown to be a major predictor of HIV disease progression and survival, is now associated with lower health care costs, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jan 2010

MabCure signs clinical research agreement to diagnose ovarian cancer

MabCure, N.V. (“MabCure”) a wholly-owned subsidiary of MabCure Inc., a biotech company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand.

7 Jan 2010

Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

CytRx Corporation, a biopharmaceutical company, today announced that the Tumor Biology Center, Freiburg, Germany, plans to initiate a Phase 2 clinical trial with CytRx’s doxorubicin prodrug INNO-206 as a treatment for patients with advanced pancreatic cancer.

6 Jan 2010

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK’s new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.

6 Jan 2010

Weill Cornell Medical College offers innovative program to teach medical students about health care system

While medical students are required to know the names of every body part and disease, most graduate with only a cursory understanding of how the health care system actually works, and some of the ways it doesn't.

6 Jan 2010

Opinions: U.S. medical emergency response; micronutrients; rotavirus vaccine; antibiotic development

"[D]espite the tireless efforts of public health and health-care workers, America's experience with H1N1 shows that the nation is not prepared to deal with a flu pandemic," former Democratic Senator Bob Graham and former Republican Senator Jim Talent write in Washington Post opinion piece that examines U.S. preparedness for medical emergencies. The writers chaired the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism.

6 Jan 2010

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.

5 Jan 2010

Restoration of natural water flows can cause ecological harm

Conservation projects often attempt to enhance the water-based transport of material, energy, and organisms in natural ecosystems. River restoration, for example, commonly includes boosting maximum flow rates.

5 Jan 2010

January issue of Chest presents new studies on COPD

A new study shows that poor lung function during adolescence and through midlife may be influenced by several factors, including birth weight, height, and gender.

5 Jan 2010

Mortality News and Research

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

Los Alamos National Laboratory identifies 'Top 10 Laboratory science stories of 2009'

Recent releases in Global Health

Health and development groups applaud Clinton speech; call for action

Ochsner Health System to acquire NSRMC

Also in global health news: Museveni on Uganda anti-gay bill; Zambia, India on collaboration; media examines water issues; Southern Sudan conflict

MUHC unveils new Lung Cancer Navigation Program

LSUHSC receives $2.1 million grant for pneumonia research

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

CCAC doubles its efforts to convince Canadians to prevent colorectal cancer

Data highlights importance of follow-up exams for patients with history of advanced adenomas

Antiretroviral therapy improves health outcomes for HIV patients

MabCure signs clinical research agreement to diagnose ovarian cancer

Tumor Biology Center to initiate Phase 2 clinical trial with CytRx’s INNO-206

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

Weill Cornell Medical College offers innovative program to teach medical students about health care system

Opinions: U.S. medical emergency response; micronutrients; rotavirus vaccine; antibiotic development

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

Restoration of natural water flows can cause ecological harm

January issue of Chest presents new studies on COPD

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News